Contact

Representative before the EPO

Employment test 1 - 10 employees
Company dna avidity ip ltd
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
no operation time available
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

James Christopher Legg has worked on the following 14 EPO patent applications which have been published in the last five years:

EP13195379

Methods of monitoring conditions by sequence analysis

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
EXAMINATION IN PROGRESS
EP12187077

Methods for generation of antibodies

IPC classification:
A01K 67/00, A01K 67/027, A01K 67/033, C07K 16/00
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843478

BIOMARKERS OF CANCER

IPC classification:
A61P 35/00, C12Q 1/68, G01N 33/50
Applicant:
The General Hospital Corporation
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
EXAMINATION IN PROGRESS
EP12844825

T-CELL RECEPTOR CLONOTYPES SHARED AMONG ANKYLOSING SPONDYLITIS PATIENTS

IPC classification:
A61K 39/395, C07K 16/18, C12N 15/12, C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
PATENT GRANTED
EP14163571

Nucleic acid quantitation from tissue slides

IPC classification:
C12N 15/10, C12Q 1/68
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
GRANT OF PATENT INTENDED
EP12854963

METHOD OF MEASURING IMMUNE ACTIVATION

IPC classification:
C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12856834

DETECTION AND MEASUREMENT OF TISSUE-INFILTRATING LYMPHOCYTES

IPC classification:
C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
James Christopher Legg, Boult Wade Tennant Ltd
Status:
EXAMINATION IN PROGRESS
EP12812999

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

IPC classification:
C07K 14/195, C12N 9/22, C12N 15/74
Applicant:
Wageningen University and Research Centre (Wageningen Universiteit)
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13738391

NANOPORE BASED MOLECULAR DETECTION AND SEQUENCING

IPC classification:
C12Q 1/68, G01N 27/26, G01N 27/414
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13748712

METHODS FOR CREATING BILAYERS FOR USE WITH NANOPORE SENSORS

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13749460

POLYMERASE ENZYME SUBSTRATES WITH PROTEIN SHIELD

IPC classification:
C12M 1/38, C12N 9/10, C12N 15/54, C12Q 1/68
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13751112

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

IPC classification:
A61K 38/00
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12187097

Methods for generation of antibodies

IPC classification:
A01K 67/00, A01K 67/027, A01K 67/033
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11777704

MONITORING HEALTH AND DISEASE STATUS USING CLONOTYPE PROFILES

IPC classification:
C12Q 1/68
Applicant:
Sequenta Inc
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
Multiple attorneys, Boult Wade Tennant Ltd
Status:
PATENT GRANTED

Please Sign in to use this feature